Streamline Health Solutions Files 8-K

TL;DR

Streamline Health filed an 8-K for shareholder votes and other events.

AI Summary

On August 7, 2025, Streamline Health Solutions, Inc. filed an 8-K report. The filing indicates that the company is submitting matters to a vote of security holders and also reports on other events and financial statements/exhibits. Specific details regarding the vote or the nature of the other events are not provided in this summary.

Why It Matters

This 8-K filing signals that Streamline Health Solutions is engaging in significant corporate actions requiring shareholder approval and is also disclosing other material events and financial information.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report indicating corporate actions and disclosures, without immediate negative or positive financial implications presented.

Key Players & Entities

• Streamline Health Solutions, Inc. (company) — Registrant
• August 7, 2025 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• 0-28132 (filing_number) — Commission File Number
• 31-1455414 (ein) — I.R.S. Employer Identification No.
• 2400 Old Milton Pkwy., Box 1353 Alpharetta, GA 30009 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 — ge on which registered Common Stock , $0.01 par value STRM Nasdaq Capital Marke

Filing Documents

• strm20250807_8k.htm (8-K) — 38KB
• 0001437749-25-025475.txt ( ) — 169KB
• strm-20250807.xsd (EX-101.SCH) — 3KB
• strm-20250807_def.xml (EX-101.DEF) — 11KB
• strm-20250807_lab.xml (EX-101.LAB) — 15KB
• strm-20250807_pre.xml (EX-101.PRE) — 11KB
• strm20250807_8k_htm.xml (XML) — 3KB

07

Item 5.07 Submission of Matters to a Vote of Security Holders. Streamline Health Solutions, Inc. (the "Company") held a Special Meeting of Stockholders (the "Special Meeting") on August 7, 2025. Proxies for the Special Meeting were solicited pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amended, and there was no solicitation in opposition to the Board's proposals. At the Special Meeting, the Company's stockholders voted upon two proposals, which are summarized below. The proposals are described in detail in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on July 10, 2025. As of the close of business on June 23, 2025, the record date for the Special Meeting, there were approximately 4,356,062 shares of the Company's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding and entitled to vote on each matter presented for vote at the Special Meeting. At the Special Meeting, 3,333,250 shares of Common Stock, or approximately 77%, of the issued and outstanding shares of Common Stock entitled to vote at the Special Meeting, were present or represented by proxy, constituting a quorum to conduct business. A brief description and the final vote results for each proposal are set forth below. 1. To adopt the Agreement and Plan of Merger, dated as of May 29, 2025 (the "Merger Agreement"), by and among the Company, Mist Holding Co., a Delaware corporation and the parent company of Hayes Management Consulting LLC d/b/a MDaudit ("Parent"), and MD BE Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which, and upon the terms and subject to the conditions set forth therein, Merger Sub will be merged with and into the Company, with the Company continuing as the surviving corporation and becoming a wholly owned subsidiary of Parent (such merger, the "Merger" and such proposal, the "Merger Proposal"): For Against Abstain Broke

01

Item 8.01 Other Events. Based on the results of the Special Meeting, the Company expects the consummation of the Merger to occur on or about August 12, 2025, subject to the satisfaction or waiver of the remaining conditions to closing set forth in the Merger Agreement.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. EXHIBIT NUMBER DESCRIPTION 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Forward-looking Statements

Forward-looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include, without limitation, projections, predictions, expectations, or beliefs about future events or results and all other statements that are not statements of historical fact. Such statements may include statements regarding the closing of the Merger and the expected timing thereof. Such forward-looking statements are based on various assumptions as of the time they are made, all of which are subject to change, and are inherently subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are often accompanied by words that convey projected future events or outcomes such as "expect," "believe," "estimate," "plan," "project," "anticipate," "intend," "will," "may," "view," "opportunity," "potential," "aim," "could," "would," "seek," "might," "considered," "continue," "target" or words of similar meaning or the negatives of these words or other statements concerning opinions or judgments of the Company or its management about future events or outcomes or that otherwise convey uncertainty about future events or outcomes. By their nature, forward-looking statements address matters that involve risks and uncertainties because they relate to events and depend upon future circumstances that may or may not occur, such as the closing of the merger and the anticipated benefits thereof. There can be no assurance that actual results, performance, or achievements of the Company will not differ materially from any projected future results, performance or achievements expressed or implied by such forward-looking statements or any related oral statements. Actual future results, pe

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STREAMLINE HEALTH SOLUTIONS, INC. Date: August 7, 2025 By: /s/ Bryant J. Reeves, III Bryant J. Reeves, III Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR